中文
Log in
ECHA Opens Public Consultation on OEL for Two Carcinogens
EU
CLP

On May 13, 2024, the European Chemicals Agency (ECHA) opened a public consultation on proposed occupational exposure limits (OEL) for 1,3-Propanesultone (CAS No. 1120-71-4) and Ethylene dibromide (EDB) or 1,2-Dibromoethane (CAS No. 106-93-4). The deadline for comments is August 12, 2024. Detailed information on these substances is provided below.

Name EC Number CAS Number Start of call Hazard classifications
1,3-propanesultone 214-317-9 1120-71-4 13/05/2024 Carcinogen, category 1B
Ethylene dibromide (EDB) or 1,2-Dibromoethane 203-444-5 106-93-4

This consultation aims to gather the latest scientific data on the specified chemicals, including their applications, exposure levels, health impacts, toxicology, epidemiology, mechanisms of action, and related information on similar substances.

Background

1,3-Propanesultone and Ethylene dibromide (EDB), or 1,2-Dibromoethane, are classified as category 1B carcinogens under the CLP regulation. 1,3-Propanesultone is commonly used as a solvent and reactive medium in chemical synthesis, while ethylene dibromide is utilized in pesticide production and organic synthesis. The use of these chemicals poses environmental and health risks, including potential damage to the central nervous system and liver or kidney dysfunction, with an increased risk of cancer from prolonged exposure.

Next Step

ECHA is set to assess the OEL for 1,3-Propanesultone and Ethylene Dibromide (EDB), per EU Directive 2004/37/EC. This effort aims to ensure the safe management of these chemicals in workplaces and prevent occupational health hazards.

After the assessments, ECHA will present its OEL recommendations to the European Commission and Member States. Necessary regulatory updates or new measures will be implemented to enhance worker health protection and workplace safety standards across Europe.

 

Further Information 

ECHA

ChemRadar
Disclaimers
1.
CIRS aims to keep the content of this site accurate and up to date. However, CIRS makes no warranties or representations regarding the quality, accuracy, completeness or reliability of information on the site.
2.
In no event shall CIRS assume or have any responsibility or liability for any information on this site or for any claims, damages or losses resulting from their use.
3.
CIRS reserves the right, at our discretion, to change, modify, add to, or remove portions of information on this site at any time without notice.
Feedbacks
Service Hotline